Categories
Pharmaceutical

Increasing Demand For Flow Cytometry Market To Push  Market Revenue Growth During   2022 – 2031 : FactMR

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

For detailed insights on enhancing your product footprint, request for a sample here https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

On the back of the aforementioned factors, the global flow cytometry market is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

Key Takeaways of Global Flow Cytometry Market Study

  • Cell-based flow cytometry shall dominate the flow cytometry market, projected to account for three-fifth of the total market during the forecast period. The ease of developing models of interconnected cellular pathways for scientists is a major driver behind the segment’s growth.
  • Products & Services-wise, the flow cytometry instruments shall constitute a major chunk of the flow cytometry market. Projections indicate a market share of around 40% for flow cytometry instruments between 2020 and 2025. Greater usage of advanced flow cytometry instruments in novel drug discovery is boosting the market.
  • Pharmaceutical and drug discoveries shall find maximum application of flow cytometry in the future. This is attributed to increased research and development activities by major pharmaceutical companies for therapeutic drug development. The segment is anticipated to hold a market share of around 45% during the forecast period.
  • Academic & Research Institutions are expected to find maximum usage of flow cytometry. The segment is expected to grow staggeringly at a CAGR of 11.6% during the forecast period. Increased research for novelty, efficacy, toxicity and safety of medicines are major drivers for the growth of this segment.
  • North America shall dominate the global flow cytometry market during the forecast period, accounting for more than one-third of the total flow cytometry market. Government campaigns to increase awareness about chronic diseases and increased research and development are factors augmenting the market growth in the region.
  • However, Asia-Pacific is expected to register stellar growth during the forecast period, expanding at a CAGR of 14%. A burgeoning pharmaceutical industry, development of new biologics, vaccines and drugs are expected to leverage future growth of the flow cytometry market.

“The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry market’s prospects in the future”, concludes a Fact.MR analyst.

For comprehensive insights on this market adoption, ask an analyst here https://www.factmr.com/connectus/sample?flag=AE&rep_id=4633

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players: Becton Dickinson & Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific Inc., SYSMEX CORPORATION, Alere Inc., Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc. & Bio-Rad Laboratories, Inc. Merck & Co. who constitute the maximum share of the market. The company invests in acquisitions that provide opportunities to supplement organic growth and strengthen product portfolios. Another player, Benton Dickinson and Company, offers Flow Cytometry Instruments, Software, Antibodies and Instruments. These products include BD FACSVerse, BDFACSCelesta and BD LSRFortessa. The company is a leading manufacturer and supplier of flow cytometry devices, antibodies and software.

Buy Now – https://www.factmr.com/checkout/4633

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Flow Cytometry Market To be Fueled by Rapid Shift in Consumer Perception and Increasing Awareness : FactMR

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

On the back of the aforementioned factors, the demand for flow cytometry is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Global Flow Cytometry Market Segmentation

Fact.MR has studied the global flow cytometry market with detailed segmentation on the basis of technology, products & services, application, end-users and key regions.

Technology
  • Cell-based
  • Bead-based
Products & Services
  • Reagents & Consumables
  • Flow Cytometry Instruments
  • Software
  • Services
Application
  • Pharmaceutical & Drug Discovery
  • Diagnostics
End-users
  • Pharmaceutical & Drug Discovery
  • Diagnostics
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Takeaways of Global Flow Cytometry Market Study

  • Cell-based flow cytometry shall dominate the flow cytometry market, projected to account for three-fifth of the total market during the forecast period. The ease of developing models of interconnected cellular pathways for scientists is a major driver behind the segment’s growth.
  • Products & Services-wise, the flow cytometry instruments shall constitute a major chunk of the flow cytometry market. Projections indicate a market share of around 40% for flow cytometry instruments between 2020 and 2025. Greater usage of advanced flow cytometry instruments in novel drug discovery is boosting the market.
  • Pharmaceutical and drug discoveries shall find maximum application of flow cytometry in the future. This is attributed to increased research and development activities by major pharmaceutical companies for therapeutic drug development. The segment is anticipated to hold a market share of around 45% during the forecast period.
  • Academic & Research Institutions are expected to find maximum usage of flow cytometry. The segment is expected to grow staggeringly at a CAGR of 11.6% during the forecast period. Increased research for novelty, efficacy, toxicity and safety of medicines are major drivers for the growth of this segment.
  • North America shall dominate the global flow cytometry market during the forecast period, accounting for more than one-third of the total flow cytometry market. Government campaigns to increase awareness about chronic diseases and increased research and development are factors augmenting the market growth in the region.
  • However, Asia-Pacific is expected to register stellar growth during the forecast period, expanding at a CAGR of 14%. A burgeoning pharmaceutical industry, development of new biologics, vaccines and drugs are expected to leverage future growth of the flow cytometry market.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4633

“The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry market’s prospects in the future”, concludes a Fact.MR analyst.

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players:

  • Becton Dickinson & Company.
  • Merck & Co.Inc.
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • SYSMEX CORPORATION
  • Alere Inc.
  • Miltenyi Biotec
  • Bio-Techne
  • Agilent Technologies Inc. 
  • Bio-Rad Laboratories Inc.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4633

Looking for more information?

The research study on the global flow cytometry market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global flow cytometry market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Technology (Cell-based and Bead-based), Products & Services (Reagents & Consumables, Flow Cytometry Instruments, Software and Services), Application (Pharmaceutical & Drug Discovery, Diagnostics and Others) and End-Users (Hospitals & Diagnostic Labs, Academic & Research Institutions and Others) across five major regions.

Report Benefits & Key Questions Answered

  • Flow Cytometry Company & brand share analysis: The report offers brand-share analysis on Flow Cytometry market to offer a more in-depth competition deep-dive. This is intended at assisting companies at proactive long-term planning.
  • Flow Cytometry Historical volume analysis: Factors affecting sales in the past are analyzed in detail. The report also offers comparative analysis between growth trajectory exhibited in 2016-2020 and 2020-2025.
  • Flow Cytometry Category & segment level analysis: To offer a comprehensive analysis, the market identifies leading segments and highlights chief factors enabling growth across these categories.
  • Flow Cytometry Consumption by demographics: The demographic analysis is intended at providing recommendations to companies to help them create growth strategies around dynamic consumption patterns.
  • Flow Cytometry Manufacturing trend analysis: Manufacturing trend analysis is the key highlight of the study. It offers vital data on strategies adopted by market players to align their manufacturing strategies as per prevailing market trends.            

Get More Insights

https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Market For Flow Cytometry Market To Record Heightened Sales During Forecast Period 2022 – 2031 : FactMR

A new forecast by Fact.MR estimates that flow cytometry revenues will expand more than twofold between 2021 and 2031, reaching US$ 12.5 Bn in 2031, following a ten-year compound annual growth rate (CAGR) of approximately 9% across the forecast period. As of 2021, the industry is poised to reach US$ 5.3 Bn. Expanding research on countering immunological disorders is spearheading growth.

From 2016 to 2020, the flow cytometry market surged at a CAGR of around 8%, to be valued at US$ 4.7 Bn by the end of the historical period. This technique received further boost amid the COVID-19 pandemic, as healthcare stakeholders leveraged it to characterize the type of T cells responsible for triggering the immune response against the disease.

Flow cytometry technology plays a vital role in basic research, drug discovery, and clinical diagnostics. Flow cytometry is currently being used more and more to measure several parameters simultaneously in a variety of clinical applications such as blood disorders in medicine. Future prospects are expected to broaden as pharmaceutical and healthcare providers look to developed advanced cancer diagnostics. By 2025, Fact.MR expects the market to reach US$ 8.1 Bn.

Request Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Key Segments Covered

  • Technology

    • Cell-based Flow Cytometry
    • Bead-based Flow Cytometry
  • Products & Services

    • Flow Cytometry Reagents & Consumables
    • Flow Cytometry Instruments
    • Flow Cytometry Software
    • Flow Cytometry Services
  • Application

    • Flow Cytometry  for Pharmaceutical & Drug Discovery
    • Flow Cytometry  for Diagnostics
    • Flow Cytometry  for Other Applications
  • End User

    • Flow Cytometry  for Hospitals & Diagnostic Labs
    • Flow Cytometry  for Academic & Research Institutions
    • Flow Cytometry  for Other End Users

Request Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4633

Key Takeaways from the Market Study

  • Cell based flow cytometry to account for 60% of global market demand
  • By products & services, flow cytometry software likely to incline at 6% CAGR
  • Flow cytometry instruments to account for 2 out of 5 sales until 2031
  • Pharmaceutical & drug discovery applications to account for 45% of flow cytometry demand
  • By end user, academic & research institutions to register over 11% CAGR until 2025
  • North America likely to yield 1/3rd of the global flow cytometry market revenue
  • Asia to register a staggering 14% CAGR until 2025, with India & China spearheading growth

Competitive Landscape

Strategic collaborations enable manufacturers to increase production and meet consumer demand which will increase revenue and market share. New products and technologies will enable end-users to benefit from products that are eco-friendly by nature.

  • On 17th September 2020, Agilent Technologies Inc. expanded its product offering with Agilent NovoCyte Penteon. As multicolor flow cytometry assays get more sophisticated, the NovoCyte Penteon offers expansions in UV excitation capabilities that allow for this to occur.

Buy Now – https://www.factmr.com/checkout/4633

More Insights Available

Fact.MR’s, in its new offering, presents an unbiased analysis of the flow cytometry market, presenting historical demand data (2016-2020) and forecast statistics from 2021 to 2031.

The study divulges essential insights on the market based on technology (cell-based, bead-based), products & services (reagents & consumables, flow cytometry instruments, software, services), application (pharmaceutical & drug discovery, diagnostics), and end-users (hospitals & diagnostic labs, academic & research institutions and others) across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Read More Trending Reports of Fact.MR: – https://www.einpresswire.com/article/557143957/demand-for-reinforced-hydraulic-hose-is-surged-owing-to-its-application-in-industrial-hydraulic-system-at-high-pressure

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com